Mind Medicine (MindMed) Inc. (MMDCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:13PM EST
| Previous Close | 0.0151 |
| Open | 0.0151 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0151 - 0.0151 |
| 52 Week Range | 0.0151 - 0.0151 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireMindMed Reports Third Quarter 2023 Financial Results and Business Highlights
NEW YORK, November 02, 2023--MindMed today reported its financial results for the quarter ended September 30, 2023.
Business WireMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update
NEW YORK, October 26, 2023--MindMed plans to host a conference call on Thursday, November 2, 2023, at 4:30 p.m. ET.
Business WireMindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
NEW YORK, October 24, 2023--Enrollment completed for MMED007, the Phase 2a study evaluating repeated low-dose administration of MM-120 for the treatment of adults with ADHD.
© 2023 Yahoo. All rights reserved.